首页> 外文期刊>Current respiratory medicine reviews >Progress and prospects of stem cells in treatment of drug resistant tuberculosis
【24h】

Progress and prospects of stem cells in treatment of drug resistant tuberculosis

机译:干细胞治疗结核病的研究进展与展望

获取原文
       

摘要

Tuberculosis (TB) is a major cause of illness and death. The worldwide epidemic of HIV/AIDS and emergence of multidrug-resistant and extensively drug-resistant TB, are exacerbating this global public health issue. In this situation, several innovative approaches are being pursued to further improve the existing measures, as well as to identify new one. Recently, stem cell transplantation has emerged as a novel therapeutic option which holds promises for the treatment of many non-infectious and infectious diseases. Recent advances and experimental studies attracted the interest of researchers for exploring the stem cellbased treatment as a candidate treatment option for drug resistant tuberculosis. To date little has been published concerning the short and long term therapeutic effect of any type of stem cells in patients suffering from drug resistant tuberculosis. The purpose of this review is to present the viewpoints on current status and future prospect of this novel treatment approach in severe form of TB and also to discuss the opportunities and challenges associated with this approach.
机译:结核病(TB)是疾病和死亡的主要原因。世界范围内的艾滋病毒/艾滋病流行以及多重耐药性和广泛耐药性结核病的出现,加剧了这一全球公共卫生问题。在这种情况下,正在采取几种创新方法来进一步改善现有措施,并确定新的措施。近来,干细胞移植已成为一种新的治疗选择,有望治疗许多非感染性和感染性疾病。最近的进展和实验研究吸引了研究者的兴趣,以探索基于干细胞的治疗作为耐药结核病的候选治疗选择。迄今为止,关于任何类型的干细胞在耐药结核病患者中短期和长期治疗效果的报道很少。这篇综述的目的是提出关于这种新的严重结核病治疗方法的现状和未来展望的观点,并讨论与这种方法相关的机遇和挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号